Placental Potpourri: the
Pernicious, Picayune, and
Pervasive
Phyllis C. Huettner, M.D.
Washington University Medical Center
St. Louis
Outline of This Talk
• Value of placental examination
• Brief review of placental circulation, histology
• Lesions that impact neonatal or maternal health
• Intrauterine infection
• Villitis of unknown etiology
• Fibrin deposition
• Other circulatory disorders
• Fetal thrombotic processes
Value of Placental Examination
• Etiology of intrauterine or perinatal death
• Etiology of preterm delivery
• Etiology of anomaly
• Etiology of neurologic impairment
• Alter management of future pregnancies
• Pathophysiology of maternal or neonatal
disorders
• Useful in the care of a sick neonate
Etiology of Stillbirth
• Classic study of perinatal autopsies
• 92% of cases had placental abnormalities
• In one-third cause of death involved placenta or
cord
• 16% placenta or cord contributed to death
Driscoll SG. Pediatr Clin North Am. 1965;12:493.
Etiology of Stillbirth
Cause of death (COD) determination in structurally normal
stillbirths
• Increased from 38.5% to 79.5% (p<.0001) after policy of
placental examination instituted
• Placental exam provided
• Confirmation of COD in 24.6%
• New diagnostic information and COD in 44.7%
• No additional info in 30.7%
Wu X et al. Mod Path 2009;22(sup 1):10A poster 33
Value of Placental Examination
• Etiology of intrauterine or perinatal death
• Etiology of preterm delivery
• Etiology of anomaly
• Etiology of neurologic impairment
• Alter management of future pregnancies
• Pathophysiology of maternal or neonatal
disorders
• Useful in the care of a sick neonate
Pathogenesis of Intrauterine Infection
• Ascending - typically bacterial → chorioamnionitis
• Transplacental - viral, protozoal, bacterial → villitis
Ascending Infection
• Most common type of infection
• Organisms enter through cervix
• Relationship with rupture of membranes
• Inflammation of fetal membranes and umbilical cord
• Neonatal pneumonia, sepsis by swallowing, aspirating infected amnionic fluid
Intrauterine Infection
Common
• See in 10% to 20% of term deliveries
• Up to two-thirds of preterm deliveries
Important associations
• Preterm delivery
• Neonatal sepsis
• Cerebral palsy
• Chronic lung disease
Chorioamnionitis
• At term - related to presence and duration of membrane rupture
• Preterm - likely precedes and causes membrane rupture
• inflammatory response produces
• prostaglandins, cytokines - trigger labor
• metalloproteinases - weaken membrane integrity, remodel cervical tissue
Intrauterine Infection
• Prematurity is leading cause of perinatal morbidity
and mortality in the US
• 70% of neonatal deaths
• 50% of cases of cerebral palsy
• Chronic lung disease, metal retardation
• Amnionic infection is a major cause of preterm
deliveries
Fetal Inflammatory Response Syndrome
• Intrauterine infection leads to production
of inflammatory cytokines by fetus
• Inflammatory response correlates with
adverse outcomes
• Neonatal sepsis
• Pneumonia
• Bronchopulmonary dysplasia, RDS
• Intraventricular hemorrhage, periventricular
leukomalacia, cerebral palsy
• Necrotizing enterocolitis
Fetal Inflammatory Response Syndrome
• UC IL-6 and AF IL-6 correlate with CP
and periventricular leukomalacia
• Acute funisitis, especially arteritis, may
be better predictor of CP than IL-6 levels
• Severe fetal outcomes occur more often
in infants with arteritis
• True after adjusting for gestational age
Yoon BH et al. Am J Obstet Gynecol 1997; 177:19.
Kim CJ et al. Am J Obstet Gynecol 2001; 185:496.
Cerebral Palsy and Chorioamnionitis
• Infection and inflammation do not explain all
cases of CP
• Other possible cofactors
• Gestational age at time of infection
• Intensity of fetal response
• Genetic differences in genes that code
cytokines
Cerebral Palsy and FIR Syndrome
Role of cytokine polymorphisms• Mannose binding lectin-221, TNF-α-308 and MBL-52, 54, 57
• These polymorphisms alter levels of circulating cytokines
• Any of these polymorphisms increased risk of CP
• Any MBL 54- ↑ risk of diplegia
• Heterozygous TNFα - ↑ risk of quadraplegia at term
• Heterozygous or homozygous TNFα - ↑ risk of hemiplegia
at <32 weeks
Gibson CS et al. Am J Obstet Gynecol 2006; 194:674
Cerebral Palsy and FIR Syndrome
Possible mechanisms
• Direct toxicity to neurons
• impair transition from oligo precursors to mature oligos
• Activate endothelial cells, shift to prothombotic state, ? Syngergism with thrombophilic polymorphisms
• ↑ permeability of blood brain barrier
• ↓ innate response to infection
Proposed Pathogenesis
Bacterial
infection↑ cytokines
Permeability of
blood brain barrier
passage of bacteria,
cytokines
Cell destruction,
abnormal proliferation
Chronic Lung Disease and FIR Syndrome
• Bronchopulmonary dysplasia (BPD) not explained by prematurity alone
• Very LBW infants with BPD
• ↑ incidence of chorioamnionitis
• ↓ respiratory distress
• BPD correlates with ↑ antenatal cytokines
• Infants with highest IL-6, IL-8, IL-1 levels had highest risk of BPD, controlled for gestational age
• Animal models – cytokines disrupt lung development by variety of mechanisms
Mittendorf R et al. J Perinat Med 2005; 33:428
Yoon BH et al. Am J Obstet Gynecol 1997; 177-825
Fetal Inflammatory Response
Chorioamnionitis and funisitis
• Presence correlates with outcomes
• Severity correlates with outcomes
• Numerous staging and grading systems
• All have shortcomings
• Reproducibility not perfect
• Lack of prospective correlation with outcomes
Ascending Infection
Better standardization of diagnostic terminology is needed
• Degree, location of inflammation related to outcome
• Stratification of prognosis
• Stratification of treatment
• Facilitate studies between institutions
Redline RW et al. have proposed a scheme for staging and grading the maternal and fetal response
Pediatr Develop Pathol 6:435-448, 2003
Ascending Infection
• Maternal response – acute chorioamnionitis
• In free membranes neutrophils emigrate from
decidual vessels through chorion and amnion
• In placenta neutrophils emigrate from intervillous
space through chorion and amnion
• Fetal response – funisitis, chorionic vasculitis
• Neutrophils emigrate from umbilical vessels
• Neutrophils emigrate from chorionic vessels
Maternal Inflammatory Response
Stage 1
• Suggested diagnostic terminology
• Acute subchorionitis or early acute chorionitis
• Definition
• Neutrophils in subchorionic fibrin and/or membranous trophoblast
Redline RW et al. Pediatr Dev Pathol 6:435-448, 2003
Maternal Inflammatory Response
Stage 1- Acute Chorionitis
Neutrophils in membrane trophoblast
Maternal Inflammatory Response
Stage 1- Early Acute Chorionitis
Neutrophils in fibrin beneath chorionic plate
Maternal Inflammatory Response
Stage 2
• Suggested diagnostic terminology
• Acute chorioamnionitis
• Definition
• Neutrophils in chorionic plate or membranous chorionic connective tissue and/or amnion
Redline RW et al. Pediatr Dev Pathol 6:435-448, 2003
Maternal Inflammatory Response
Stage 2 – Acute Chorioamnionitis
Scattered neutrophils in chorion and amnion
Maternal Inflammatory Response
Stage 3
• Suggested diagnostic terminology
• Necrotizing chorioamnionitis
• Definition
• Neutrophil karyorrhexis, amnion necrosis and/or amniotic basement membrane thickening/hypereosinophilia
Redline RW et al. Pediatr Dev Pathol 6:435-448, 2003
Maternal Inflammatory Response
Stage 3
Neutrophils with karyorrhexis
Maternal Inflammatory Response Stage
3 – Necrotizing Chorioamnionitis
Amniotic epithelial necrosis; thickened, eosinophilic basement membrane
Maternal Inflammatory Response
Grade 1 – Mild-Moderate
• Suggested diagnostic terminology
• Mild or moderate
• Definition
• Individual or small clusters of neutrophils
Redline RW et al. Pediatr Dev Pathol 6:435-448, 2003
Maternal Inflammatory Response
Grade 1- Mild-Moderate
Scattered neutrophils
Maternal Inflammatory Response
Grade 2 - Severe
• Suggested diagnostic terminology
• Severe acute chorioamnionitis or with
subchorionic microabscesses
• Definition
• Confluent neutrophils between chorion
and decidua; > or equal to 3 isolated foci
or continuous bandRedline RW et al. Pediatr Dev Pathol 6:435-448, 2003
Maternal Inflammatory Response
Grade 2 - Severe
Confluent band of neutrophils
Fetal Inflammatory Response
Stage 1
• Suggested diagnostic terminology
• With chorionic vasculitis or umbilical
phlebitis
• Definition
• Intramural neutrophils in chorionic vessels
and/or umbilical vein
Redline RW et al. Pediatr Dev Pathol 6:435-448, 2003
Fetal Inflammatory Response
Stage 1 - Phlebitis
Neutrophils in smooth muscle of umbilical vein wall
Fetal Inflammatory Response
Stage 1 - Chorionic Vasculitis
Neutrophils in wall of large chorionic vessels on fetal plate
Fetal Inflammatory Response
Stage 2
• Suggested diagnostic terminology
• With umbilical vasculitis (one or both arteries
+/- vein) or umbilical panvasculitis (all
vessels)
• Definition
• Intramural neutrophils in umbilical artery or
arteries (+/- vein)Redline RW et al. Pediatr Dev Pathol 6:435-448, 2003
Fetal Inflammatory Response
Stage 2 - Arteritis
Neutrophils in smooth muscle of wall of umbilical artery
Fetal Inflammatory Response
Stage 3
• Suggested diagnostic terminology
• With necrotizing funisitis or with concentric
umbilical perivasculitis
• Definition
• Neutrophils +/- debris in concentric bands-
rings-halos around one or more umbilical
vesselsRedline RW et al. Pediatr Dev Pathol 6:435-448, 2003
Fetal Inflammatory Response
Stage 3 - Necrotizing Funisitis
Neutrophils and debris ring the umbilical vessels
Fetal Inflammatory Response
Stage 3 - Necrotizing Funisitis
Fetal Inflammatory Response
Grade 1 - Mild-Moderate
• Suggested diagnostic terminology
• Mild – moderate
• Definition
• Scattered neutrophils
Redline RW et al. Pediatr Dev Pathol 6:435-448, 2003
Fetal Inflammatory Response
Grade 2 - Severe
• Suggested diagnostic terminology
• With a severe fetal inflammatory response or
with intense chorionic (umbilical) vasculitis
• Definition
• Near confluent intramural neutrophils in
chorionic and/or umbilical vessels with
attenuation/degeneration of vascular smooth
muscle
• Redline RW et al. Pediatr Dev Pathol 6:435-448, 2003
Chorionic Vasculitis with Thrombi
Chorionic Vasculitis with Thrombi
Chorionic Vasculitis with Thrombi
Ascending Infection
• Rarely see causative organisms in sections
• Exceptions:
• Group B beta-hemolytic streptococcus
• Fusobacterium
• Candida
Group B beta-hemolytic strep
Bacterial colonies with no inflammatory response
Hematogenous Infection
• Virus – CMV, Rubella, Varicella, Parvovirus, HSV
• Bacteria – Treponema pallidum, Listeria
• Parasites – Toxoplasma gondii
• Unknown – > 95%, ? abnormal immune reaction
Hematogenous Infection
Clinical Impact
• Spontaneous abortion – Rubella
• Fetal death in utero, stillbirth – Parvovirus
• Malformations – Rubella, Toxo
• Active infection – Toxo, CMV
• Delayed sequelae – CMV and others
• Deafness
• Mental retardation
• Learning disabilities
Villitis
Type acute, chronic, granulomatous
Composition lymphs, histiocytes, plasma
cells, neutrophils
Necrosis necrotizing, non-necrotizing
Distribution focal, diffuse, basal
Severity very mild, mild, mod, severe
Villitis
Collections of abnormally agglutinated villi
Villitis
Necrotizing villitis
Villitis
Non necrotizing villitis
Villitis
Granulomatous villitis
Villitis
Basal villitis
Villitis
• > 95% is villitis of unknown etiology (VUE)
• Certain features do point to infections as the
etiology
• Clinical history
• Active, resolving, healed areas
• Prominent fibrosis
• Often associated acute chorioamnionitis
• Specific features
Infectious Villitis
Confirm with
• Special stains
• Molecular techniques
• Maternal/infant serology
• Detailed clinical history
Congenital CMV Infection
0.2% to 2.5% of live births
• 5% to 10% have disseminated disease
• 90% unrecognized at birth
• 5% to 15% have long-term effects
• Mental retardation
• Learning disabilities
• Sensorineural hearing loss
Congential CMV Infection
• In utero > intra partum, post partum
• Caused by 1º or 2º infection
• If 1º more likely:
• Symptomatic
• Late sequelae
• Treatment immediately after birth may
decrease severity of neurologic damage
Congenital CMV Infection
• Recent evidence that decidual cells or
decidual macrophages are reservoir for
CMV
• Reactivation is more likely after
inflammatory response to bacterial
infections
Congenital CMV Infection
• Usually infected women are asymptomatic
• No guidelines for treating CMV during
pregnancy
• Role of screening pregnant women for
CMV is unclear
CMV Placentitis
• Lymphoplasmacytic villitis
• Necrotizing vasculitis
• Vessel occlusion
• Stromal hemosiderin
• Viral inclusions – 20%
CMV
Necrotizing villitis
CMV
Numerous plasma cells – important clue to CMV
CMV
Vascular sclerosis
CMV
Vascular sclerosis
CMV
Stromal sclerosis
CMV
Stromal hemosiderin and sclerosis
CMV
Inclusions in stromal cells
CMV
Inclusions in endothelial cells
CMV
Eosinophilic nuclear and basophilic cytoplasmic inclusions
CMV
CMV Placentitis
Immunohistochemistry, in situ
hybridization and PCR will detect CMV in
cases of congential infection
• When placenta is normal
• When infection is sub clinical
Villitis of Unknown Etiology
• Accounts for majority of villitis
• Incidence
• 6% to 26% of placentas
• Usually greater than 32 weeks gestation
• No gross abnormalities
• 85% are focal
• Most randomly distributed
• 20% have basal location
Villitis of Unknown Etiology
• Most cases are necrotizing
• Most are lymphohistiocytic
• Most cases are focal
• May be associated with vasculitis of fetal
stem vessels
• Avascular downstream terminal villi
Villitis of Unknown Etiology
Theories of pathogenesis
• Result of unidentified pathogen
• Immunologic phenomenon
Villitis of Unknown Etiology
• Inflammatory cells
• Maternal
• T helper cells
• Ia antigen-bearing macrophages
• incidence in women with autoimmune
disorders
• Tendency to recur
Villitis of Unknown Etiology
Clinical associations
Severity of clinical findings generally related
to severity of villitis
• Small for gestational age infants
• Antenatal growth arrest
• Perinatal mortality
• Oligohydramnios without membrane rupture
• Chronic monitoring abnormalities
Villitis of Unknown Etiology
Which cases to work up for infection?
• Suspicious maternal history
• Suspicious clinical findings in neonate
• Not mild
• Pattern besides lymphohistiocytic
Villitis
Basic work up
• IHC for CMV
• IHC for toxoplasma
• Warthin-Starry or IHC for spirochetes
• Gram stain if lots of neutrophils or abscesses
Important Circulatory Disorders
• Abnormal fibrin deposition
• Massive perivillous fibrin
• Maternal floor infarct
• Infarction
• Retroplacental hematoma
Perivillous Fibrin
• See some fibrin in most placentas
• Grossly visible fibrin in 22%
• Underneath chorionic plate
• Around stem villi
• Just above basal plate
• See less in preeclampsia (13%)
• See less in preterm (6%)
Normal Fibrin Deposition
Normal Fibrin Deposition
Above basal plate
Fibrin Deposition
Gross
• Firm, tan, yellow or white
• Fuzzy border
• Interspersed red villous tissue
• Not as well circumscribed as infarct
• Often in periphery
Perivillous Fibrin Deposition
Massive Perivillous Fibrin
Deposition
Perivillous Fibrin Deposition
Not as well circumscribed as infarcts
Perivillous Fibrin Deposition
Expansion of intervillous space
Perivillous Fibrin Deposition
Cytotrophoblast proliferation
Perivillous Fibrin Deposition
Differential diagnosis
• Infarct
• Also firm, white if not recent
• Well circumscribed
• Collapse, not expansion, of intervillous space
• No trophoblast proliferation
• Maternal floor infarct
• Involves the basal villi and decidua
Perivillous Fibrin Deposition
Clinically significant if:
• Entraps 20% of terminal villi
• Central-basal location
Clinical significance
• Intrauterine growth retardation
• Low placental weight
• Fetal death in utero
Redline RW, Patterson P. Arch Pathol Lab Med 1994; 18:698
Perivillous Fibrin Deposition
Katzman and Genest
• Transmural massive fibrin deposition (MFD)
• Extends from fetal to maternal surface
• Entraps > 50% of villi on at least one slide
• Rare - 0.28 to 0.5% of examined placentas
Pediatr Dev Pathol 2002;5:159-164
Perivillous Fibrin Deposition
Katzman and Genest
• 31% of infants had IUGR
• 14% had MFD or maternal floor infarct
in other 2nd or 3rd trimester pregnancies
• 50% had MFD or maternal floor infarct
in other 1st trimester pregnancies
Pediatr Dev Pathol 2002;5:159-164
Perivillous Fibrin
• Pathogenesis is unclear
• Likely related to stasis and thrombosis of
maternal blood
Perivillous Fibrin
• Massive perivillous fibrin in small for gestational age (SGA) and prior SGA
• Preeclampsia, collagen vascular diseases, coagulopathy
• Aspirin, dipyridamole prevents perivillous fibrin and SGA
Fuke Y et al Gyn Obstet Invest 38:5-9, 1994
Maternal Floor Infarct
Maternal Floor Infarct
Maternal Floor Infarct
Maternal Floor Infarct
• Infarct is a misnomer - fibrinoid deposition
• Fibrinoid involves decidua basalis
• Encases adjacent villi
• Katzman and Genest definition
• Basal villi of entire maternal floor be encased by fibrinoid at least 3 mm thick on at least one slide
Pediatr Dev Pathol 2002;5:159-164
Maternal Floor Infarct
• Stillbirth – 13% to 50%
• Growth retardation - 24 to 100%
• Preterm delivery – 26% to 60%
• Independent predictor of neurologic
impairment in preterm infants
• Recurrence – 12% to 78%
Subchorionic Fibrin Deposition
Not clinically significant
Subchorionic Fibrin
Layers of blood and fibrin beneath chorionic plate
Subchorionic Fibrin
• Not clinically significant
• May reflect damage to fetal plate by fetal
movements
• Less common in infants with disorders that
restrict movement
Infarcts
Firm, well circumscribed, often pale
Infarcts
Well circumscribed
Usually abut the maternal surface
May be red, tan, or white
Extensive Infarction
Infarcts
Loss of intervillous space
Infarcts
Ghost villi with thick trophoblast membranes
Infarcts
Differential diagnosis
• Perivillous fibrin deposition
• Intervillous thrombohematoma
• Also well circumscribes, white if not recent
• Often laminated
• Contain no villi, only blood
Intervillous Thrombohematoma
Well circumscribed, laminated, red if early, white if older
Infarcts
Pathogenesis
• Decreased blood supply to group of villi
• Vessel narrowing (hypertension)
• Atherosis (preeclampsia)
• Physical separation (retroplacental
hematoma)
Normal Vascular Remodeling
• Replacement of smooth muscle and elastic by
fibrinoid material
• Vessels become flaccid, low resistance tubes
• Increases blood flow 10-fold
Decidual Vasculopathy
Two forms
• Lack of physiologic transformation
• Acute atherosis
• Both are associated with
• Preeclampsia
• IUGR
• Small for gestational age infants
• Collagen vascular disease
Implantation Site Vessels
Prominent endovascular trophoblast
Acute Atherosis
Prominent fibrinoid necrosis, very narrow lumens
Acute Atherosis
Infarcts
Normal
• See in 10-25% of term placentas
• Small, located in periphery
Clinically significant if:
• Multiple, central
• Large (>3 cm)
• Preterm
Infarcts
Clinical significance for fetus
• Hypoxia
• Intrauterine growth restriction
• Periventricular leukomalacia (preterm)
• Intrauterine fetal demise
Infarcts
Clinical significance for the mother
• Extensive implies significant maternal disease
• Preeclampsia - severity related to extent of
infarction
• Maternal thrombophilic conditions
Infarcts
• Sample areas away from infarcts
• Determine overall perfusion of placenta
• Small, narrow villi, few vessels,
increased knots indicates poor perfusion
• Normally perfused placenta can lose ~20%
of villi without harming infant
• Less reserve if already poorly perfused
Low Flow Changes
Small, thin, unbranched villi
Increased syncytial knots
Retroplacental Hematoma
Densely adherent clot indents surface, underlying infarction
Retroplacental Hematoma
Retroplacental Hematoma
Blood clot indents placenta, underlying infarction
Retroplacental Hematoma
Retroplacental Hematoma
Villous stromal hemorrhage may be seen beneath, especially
in the 2nd trimester
Retroplacental Hematoma
Incidence ~ 5%
Clinical associations
• Preeclampsia
• Heavy smoking, cocaine
• Trauma
• Acute chorioamnionitis
• Maternal thrombophilic conditions
• Prior abruption
Retroplacental Hematoma
Postulated pathogenesis
• Atherosis (preeclampsia) – weakened
vessels
• Cocaine, cigarettes – spasm
• Thrombophilia - thrombosis
Placental Abruption
A clinical syndrome
• Vaginal bleeding
• Increased uterine tone
• Uterine tenderness
• Decreased fetal heart tones
• Maternal hypotension, DIC
Retroplacental Hematoma
• 30% with abruption have hematoma
• 35% with hematoma have abruption
• Clinical significance
• Depends on size, amount of infarction,
how well rest of placenta is perfused
• Fetal death
• Periventricular leukomalacia (preterm)
Marginal Hematoma
Marginal Hematoma
Marginal Hematoma
• Blood clot located between disc edge and
membranes
• Often associated with hematoma on membranes
• Occurs in placentas implanted close to os
• Causes bleeding during delivery
• Clinically mistaken for “abruption”
• Not clinically significant – no associated
infarction
Circulatory Disorders
Disorders of maternal circulation
• Perivillous fibrin deposition
• Maternal floor infarct
• Infarct
• Intervillous thrombohematoma
• Retroplacental hematoma
• Marginal hematoma
Fetal Vascular Obstruction
May occur at any level
• Umbilical cord vessels
• Chorionic plate vessels
• Small vessels in villi
Fetal Vascular Obstruction
• Fetal circulation of placenta and of fetus
itself are connected during gestation
• Vascular obstruction in fetal circulation of
placenta may be associated with and serve
as a marker for thrombotic or embolic
lesions in circulation of fetus
Fetal Vascular Obstruction
Well circumscribed, pale but not firm
Fetal Vascular Obstruction
Fetal Vascular Obstruction
Well circumscribed area of pale, fibrotic villi
Fetal Vascular Obstruction
Fetal Vascular Obstruction
Thrombosis of larger vessels, downstream avascular terminal villi
Fetal Vascular Obstruction
Fetal Vascular Obstruction
Sclerosis of vessels in higher order villi, avascular terminal villi
Villous Stromal-Vascular Karyorrhexis
Karyorrhexis in fetal vessels, fragmented red cells
Chorionic Plate Vessel Thrombus
with Calcification
Chorionic Plate Vessel Thrombus
Fetal Vascular Obstruction
Pathogenesis
• Stasis
• Hypercoagulability
• Vascular damage
Fetal Vascular Obstruction
Clinical Associations
• Maternal diabetes
• Maternal thrombophilia (but
not fetal thrombophilia)
• Chorioamnionitis
Fetal Thrombotic Vasculopathy
Unanswered questions:
• Incidence from prospective data
• Predictive value
• Clinically significant amount
• Appropriate work up
• Role of treatment in next pregnancy
• Pathogenesis
Maternal Thrombophilic Conditions
• Antithrombin III deficiency
• Protein C deficiency
• Protein S deficiency
• Factor V mutation (Leiden)
• Prothrombin 20120A
• MTHFR C677T- hyperhomocysteinemia
Maternal Thrombophilic Conditions
Clinical associations
• Controversial
• Preeclampsia
• Late pregnancy loss
• Intrauterine growth restriction
Hereditary Thrombophilic Conditions
• Problems
• Poor study design
• Imprecise placental terminology
• May be associated with
• ↑ number, ↑ size of infarcts
• Acute atherosis, spiral artery thrombi
• Retroplacental hematoma/abruption
• Fetal vascular obstruction
Fetal Vascular Obstruction
• Cord abnormalities
• Long cord
• Velamentous insertion
• Excess twisting
• Nuchal cord
Fetal Vascular Obstruction
Consequences for fetus if extensive:
• Fetal growth restriction
• Chronic monitoring abnormalities
• Stillbirth
• Neurologic impairment
• Hepatic failure
• Vascular compromise involving kidneys, GI
Fetal Thrombotic Vasculopathy
84 consecutive perinatal autopsies
• 16 (19%) had avascular terminal villi
• extensive in all 16
• Involved 25 to 50% of placenta in 4
• 6 (37.5%) had fetal somatic thrombi
• 5/8 mothers had coagulation abnormalities
Kraus FT, Archeen V Human Pathol 30:759, 1999
Fetal Thrombotic Vasculopathy
125 cases from children with neurologic deficits
referred for litigation
• 4 vascular lesions significantly increased
• Fetal thrombotic vasculopathy
• VUE with obliterative fetal vasculopathy
• Chorioamnionitis with fetal vasculitis
• Meconium-associated vascular necrosis
Redline RW Am J Obstet Gynecol 2005; 192:452-7
Fetal Vascular Obstruction
• One or more of these seen in 51% of cases
vs. 10% of controls
• 52% of CP patients had one of these lesions
• Cord abnormalities more common in infants
with fetal thrombotic vasculopathy
Redline RW Am J Obstet Gynecol 2005; 192:452-7
Redline RW Hum Pathol 2004;35:1494-8
1
Placental Potpourri: the Pernicious, Picayune, and Pervasive
Phyllis C. Huettner, M.D.
Washington University Medical Center
The placenta is a remarkable organ. It undergoes rapid growth and profound changes in
structure to supply the needs of the rapidly growing fetus for the crucial first 40 weeks of
development. During life in utero, the circulation of the fetus and the circulation of the placenta
form one continuous unit. Examination of the placenta, which is easily accessible, may provide
valuable information about events during gestation affecting the fetus.
I’ll begin by discussing the importance of placental examination. The remainder of the
talk will focus on those placental abnormalities that are clinically important for the infant, the
mother or both. Some of these abnormalities are common but others are easily overlooked.
Several have a risk of recurrence in subsequent pregnancy. Many represent areas where we have
made important new discoveries in terms of pathophysiology with important implications for
fetal and maternal health.
Why Examine the Placenta? Placental examination can be very rewarding in determining the cause of an intrauterine
or perinatal death; investigations of such deaths are incomplete without a placental examination.
In a large, classic study of perinatal autopsies, placental abnormalities were found in 92% of
cases. The cause of death was a placental or cord abnormality in almost a third of cases and in
16% of cases was a contributing factor.1 In more recent studies of structurally normal stillborn
infants, examination of the placenta significantly increased the percentage of cases in which a
cause of death could be determined.2,3
Examination of the placenta may help explain the etiology of a preterm delivery, a
congenital anomaly or other adverse neonatal outcome. Obstetrical management of subsequent
pregnancies may be altered if conditions that show a risk of recurrence such as abruption,
massive perivillous fibrin deposition, or maternal floor infarct are identified on placental
examination. Information that may help explain the outcome of a neurologically impaired child
and be useful in the legal defense of these cases may be obtained from placental examination.4,5
In a general way, examination of placentas has provided and will continue to provide insights
into the pathophysiology of various important maternal and neonatal disorders potentially
improving diagnosis and therapy for these conditions.
The information obtained from placental examination may be immediately useful in the
care of a sick neonate and may be very helpful to parents and pediatricians caring for impaired
children later in life. In order to maximize the value of placental examination, pathologists and
informaticians need to develop better ways to ensure that the results of the placental examination
reach and are understood by the neonatologists and general pediatricians caring for children and
communicating with parents, in addition to the obstetrician who sent the placenta for
examination. This is challenging because mothers and babies frequently have different last
names and are often cared for in different hospitals.
Infection and the Placenta Intrauterine infections can have important consequences for the fetus including abortion,
stillbirth, active infection in the newborn period and long-term sequelae such as neurologic
deficits including cerebral palsy, mental retardation, blindness, deafness and learning disabilities.
2
There are two broad patterns of placental infection - ascending infections and
hematogenous infections, each associated with a characteristic type and pattern of inflammation
within the placenta as well as characteristic organisms. In general, ascending infections, the most
common pattern, are caused by bacteria that pass from the vagina or cervix into the uterus and
cause acute inflammation of the fetal membranes (acute chorioamnionitis) and umbilical cord
(acute funisitis). In hematogenous infections, a less common pattern, organisms are passed
hematogenously from the mother to the placenta and fetus. This is the pattern typically seen in
TORCH infections and may be caused by viral organisms (CMV, Rubella and others), protozoa
(Toxoplasma gondii) and some bacteria (Listeria monocytogenes, Treponema pallidum). The
placenta usually shows chronic inflammation of the villi (villitis) but may also have a component
of chorioamnionitis. Infants may also be infected with bacterial or viral agents after passing
through an infected birth canal, a common form of infection with HIV and HSV, but this form of
transmission does not involve the placenta.
Ascending Infection and Acute Chorioamnionitis
Chorioamnionitis is the most common form of inflammation in the placenta. It is found in
the placentas of about 10 to 20% of term deliveries.6
Chorioamnionitis is strongly correlated with
prematurity; about two-thirds of infants born before 24 weeks gestation will have evidence of
chorioamnionitis.6
The prevalence is also increased in women of low socioeconomic status and
African-American women.7
A distinction needs to be made between clinical and histologic
chorioamnionitis. Clinical chorioamnionitis is characterized by some combination of fever,
elevated maternal white count, premature rupture of membranes and foul vaginal discharge. The
gold standard for diagnosis, however, remains histologic chorioamnionitis with the presence of
neutrophils in the chorion and/or amnion. There is very poor correlation between the clinical
diagnosis of chorioamnionitis and histologic chorioamnionitis; 72% of cases with histologic
chorioamnionitis don’t meet the clinical diagnosis and 9% of cases with clinical chorioamnionitis
don’t have histologic chorioamnionitis.8
It is now clear that infection causes acute chorioamnionitis. The implicated organisms
may be aerobic or anaerobic and are typically normal flora or gastrointestinal contaminants of
the vagina and cervix. Factors such as rupture of membranes, cervical dilatation, and the
presence of an IUD or cerclage may facilitate spread to the amnionic cavity. There is a strong
relationship between rupture of membranes and chorioamnionitis, the risk of chorioamnionitis
increasing with increasing duration of membrane rupture.9 This relationship is particularly strong
at term. In other cases, chorioamnionitis may precede rupture of membranes actually causing
premature rupture of membranes and/or preterm birth.10
The organisms seen in preterm labor
with intact membranes are typically low virulence vaginal and enteric organisms.11
There is
increasing evidence that some of these organisms may ascend from the lower GYN tract weeks
or even months before acute chorioamnionitis develops and reside in the uterine tissues including
the decidua due to decreased local immunity secondary to pregnancy.10
Pathologic Features and Grading of Acute Chorioamnionitis
The fetal membranes in chorioamnionitis are typically normal on gross examination but
in cases of severe or longstanding infection, may be discolored, friable and foul smelling. Both
the mother and the fetus (after about 20 weeks) respond to infection in the amniotic cavity.
Maternal neutrophils first migrate from the intervillous space, which is essentially a maternal
blood vessel, and accumulate in the fibrin layer beneath the chorion. From here they pass
through the connective tissue of the chorion and eventually into the amnion of the fetal plate of
the placenta in response to chemotactic factors generated by bacteria in the amnionic fluid.
3
Maternal neutrophils also migrate from maternal blood vessels in the decidua, through the
decidua, the chorion and eventually into the amnion of the free membranes (membrane roll).
Fetal neutrophils migrate out of large vessels on the chorionic plate (chorionic vasculitis) and
may also migrate from the umbilical cord vessels, typically first from the umbilical vein then by
the artery. Neutrophils are first seen in the clear spaces between smooth muscle cells but
eventually migrate completely through the vessel wall to involve the surrounding Wharton’s
jelly. If severe, rings or arcs of degenerating neutrophils will surround the umbilical vessels.
Typically, causative organisms are not seen on histologic sections. Important exceptions
include Group B streptococcus, Candida and fusobacterium. When organisms are identified, it is
important to consider post delivery overgrowth in unfixed specimens, especially those without
inflammation.
Because of the increasingly clear relationship between acute chorioamnionitis and
adverse fetal outcomes, including long-term sequelae such as cerebral palsy and chronic lung
disease (see below), standardized grading and staging of chorioamnionitis and funisitis may
facilitate study and potentially even treatment of this common condition. While many schemes
for grading and staging chorioamnionitis have been proposed, none is completely reproducible or
prospectively validated for correlation with outcomes. The scheme proposed by Redline and his
colleagues in the Society for Pediatric Pathology has good reproducibility and can serve as a start
toward standardization.12
In this system both the stage (localization) and grade (severity) are
determined for the maternal inflammatory response (chorioamnionitis) and the fetal
inflammatory response (chorionic vasculitis and funisitis). Maternal inflammatory response
(MIR) stage 1 represents acute subchorionitis and/or acute chorionitis in which neutrophils are
seen in the subchorionic fibrin layer or at the junction of decidua and chorion in the free
membranes. MIR stage 2 represents acute chorioamnionitis in which neutrophils extend into the
amnionic connective tissue or epithelium. MIR stage 3 represents necrotizing chorioamnionitis
characterized by karyorrhexis of neutrophils, hypereosinophilia of the amnionic basement
membrane and at least focal necrosis of the amnionic epithelium. MIR grade two is
characterized by chorionic microabscesses composed of 10 to 20 neutrophils; less inflammation
than this represents MIR grade 1. Fetal inflammatory response (FIR) stage 1 represents
inflammation around the large vessels of the chorionic plate (chorionic vasculitis) or the
umbilical vein. FIR stage 2 represents umbilical arteritis with or without chorionic vasculitis or
umbilical vein inflammation and FIR stage 3 represents necrotizing funisitis. Grade 2 is severe
inflammation and inflammation less than this is grade 1.
Clinical Consequences of Acute Chorioamnionitis and the Fetal Inflammatory Response
Syndrome
The pathogenesis of acute chorioamnionitis is likely different in term and preterm
gestations. In term gestations there is a strong relationship between the presence of ruptured
membranes and the duration of membrane rupture, and the likelihood of developing acute
chorioamnionitis. In contrast, in many preterm gestations, it appears that chorioamnionitis
precedes and, in fact causes premature membrane rupture and frequently preterm labor. In this
situation, low virulence organisms such as Ureaplasma and Mycoplasma ascend into uterine
tissues, perhaps very early in pregnancy, and eventually extend from decidua to chorion to
amnion and eventually into the amniotic fluid. Uterine contractions can be induced by
inflammatory cytokines such as IL-1, IL-6 and tumor necrosis factor produced as a result of the
inflammatory response.10, 13, 14
The inflammatory response also releases other factors such as
metalloproteases that degrade the extracellular matrix of the membranes and remodel cervical
collagen leading to premature cervical ripening and membrane rupture.15
4
In the past, it was thought that the adverse outcomes experienced by many infants with
acute chorioamnionitis were largely the result of the associated preterm labor, preterm delivery
and prematurity. We have now come to understand that acute chorioamnionitis leads to a fetal
reaction pattern known as the fetal inflammatory response syndrome (FIRS) and that this
reaction pattern is important in the pathogenesis of many of the adverse outcomes these infants
experience.16
The FIRS is defined by systemic inflammation and elevated levels of fetal
inflammatory cytokine IL-6.17
FIRS correlates with a variety of adverse clinical outcomes
including respiratory distress syndrome, neonatal sepsis, pneumonia, bronchopulmonary
dysplasia, intraventricular hemorrhage, perventricular leukomalacia and necrotizing
enterocolitis.16
The morphologic correlates of this fetal systemic inflammatory response are
funisitis and chorionic vasculitis. Inflammation of the umbilical artery is better correlated with
elevated IL-6 levels and adverse outcomes than inflammation of the umbilical vein.18, 19
Fetal
vascular inflammation with associated thrombosis is even more strongly correlated with poor
prognosis.20
One of the most devastating long term complications associated with chorioamnionitis is
cerebral palsy. Eastman and DeLeon noted in 1955 that infants born to mothers with fever have
a seven-fold increased risk of cerebral palsy.21
Others have noted a relationship between
histologic acute chorioamnionitis and cerebral palsy, particularly among preterm low and very
low birth weight infants.22-25
There is experimental evidence linking infection to white matter
lesions.26
Evidence that the FIRS is involved include the relationship between increased
amnionic fluid cytokines and fetal plasma cytokines with intraventricular hemorrhage, white
matter damage and cerebral palsy.25, 27
The morphologic correlates of the FIRS, acute funisitis
and chorionic vasculitis, are also associated with increased risk of intraventricular hemorrhage,
white matter damage and cerebral palsy.28-30
In fact, funisitis has been found to be a more
specific predictor of poor neurologic outcomes in newborns than IL-6 levels in cord venous
blood.31
Leviton proposed several mechanisms by which inflammatory cytokines released during
intrauterine infection might cause damage to the developing brain in the form of periventricular
leukomalacia. These include: 1). fetal hypotension leading to brain ischemia 2). Stimulation of
tissue factor production and release which may activate hemostasis resulting in coagulation
necrosis of white matter 3). Release of platelet activating factor which acts as a membrane
detergent to directly damage brain tissue and 4). TNF a directly damages oligodendrocytes and
disrupts myelinization.32
Others have noted that cytokines increase the permeability of the blood
brain barrier allowing microbial products and cytokines themselves into the brain.33
Certain
cytokines such as IL1 and TNFα activate astrocytic populations which further disrupts the
programmed sequence of normal development.33
An individual’s response may be modified by
various factors. For example genetic polymorphisms in the inflammatory cytokine genes appear
to increase the risk for cerebral palsy.34-36
An equivalent cytokine response may have very
different effects in preterm infants compared to term infants.
The FIRS has also been implicated in the development of bronchopulmonary dysplasia
(BPD).37
Several lines of evidence support the relationship between this form of severe chronic
lung disease and the FIRS, which though more common in premature infants, is not explained by
prematurity and treatment of respiratory distress alone. Very low birthweight infants who
develop BPD have an increased incidence of chorioamnionitis but less respiratory distress.37
The
risk of BPD is increased with antenatal exposure to inflammatory cytokines.38
Those preterm
infants with intact membranes who had the highest IL-6, IL-8, and IL1b levels were at the
greatest risk of developing BPD even when controlled for gestational age.38, 39
In animal models,
these inflammatory cytokines disrupt lung development by a variety of mechanisms including
5
apoptosis of lung cells, decreased proliferation of certain lung cell populations, inhibition of
microvascular development, and decreased expression of numerous growth.16
Administration of
an antagonist to IL-1 prior to endotoxin administration prevents many of these changes.16
Hematogenous Infection Infectious agents may reach the placenta by hematogenous spread from the mother.
Usually organisms that infect the placenta in this way are viruses (TORCH infections) but this
pattern of spread may be seen with some bacterial infections, such as Listeria and syphilis and
parasitic infections such as toxoplasmosis. The morphologic manifestation of infections that
reach the placenta by the hematogenous route is typically villitis, or inflammation of the villi.
Gross Features
Villitis is usually not appreciated on gross examination of the placenta. Occasionally,
small foci of necrosis may be seen. Sometimes placentas with villitis are enlarged and pale
(syphilis and toxoplasmosis). In some infections, particularly Listeria, abscesses may be apparent
on gross examination.
Microscopic features
Microscopically, the hallmark of a hematogenous infection is an inflammatory infiltrate in
the villi. The inflammatory cells may be lymphocytes, histiocytes, plasma cells and,
occasionally, neutrophils or a mixture of these. Rarely, villitis may be composed of
granulomatous inflammation. Despite their location within the villi, studies have shown that the
lymphocytic inflammatory cells are predominantly of maternal origin.40
There is often associated
necrosis of the villous trophoblast and prominent villous agglutination with eosinophilic
fibrinoid material; however, in some cases the inflammatory cells infiltrate the villi without
destruction. Sometimes the majority of the inflammation is present around the villi
(intervillositis). In addition to inflammation, the involved villi may show vascular destruction,
stromal hemosiderin and fibrosis. Usually when the etiology is infectious, areas of active
inflammation, resolving villitis and healed villitis with prominent fibrosis are scattered in a
patchy distribution throughout the placenta. Often cases with an infectious etiology have
associated chorioamnionitis. Sometimes the villitis is localized to a particular area such as stem
villi or basal plate. This distribution does not appear to be related to the etiology.
Clinical Significance
The consequences of a hematogenous infection can be devastating and include such
outcomes as stillbirth, mental retardation, learning disabilities, blindness and deafness.
Therefore, it is very important for pathologists to have a high index of suspicion for infection.
The morphologic features of some of the well known infectious agents can sometimes point to a
particular infectious etiology that may be confirmed with immunohistochemistry, PCR, infant
and maternal serologies, or even a detailed clinical history. It is important to keep in mind,
however, that in the vast majority of cases of villitis (>95%) an infectious agent will not be
identified on histologic sections, culture or ancillary techniques. These cases represent villitis of
unknown etiology or VUE (see below). While a detailed discussion of the pathology of all the
various infectious agents that may infect the placenta and fetus is beyond the scope of this
discussion, I would like to examine the features of the most common infectious agent in the US
to infect the infant by the hematogenous route: cytomegalovirus.
6
Cytomegalovirus (CMV)
Gross and microscopic features
The placenta may be normal, small, if the fetus is growth restricted, or enlarged and pale,
if the fetus is anemic. The characteristic microscopic features of CMV villitis are
lymphoplasmacytic inflammatory infiltrates, stromal hemosiderin, necrotizing vasculitis,
occluded villous vessels and villous necrosis.41
In about 20% of cases the characteristic
eosinophilic intranuclear and basophilic cytoplasmic inclusions can be identified in stromal,
endothelial, Hofbauer or trophoblast cells. Immunohistochemistry, in situ hybridization and PCR
will detect CMV in the placenta of cases of congenital CMV infection even in cases that are
normal histologically or in which the infection is.42-44
In a study of 94 term placentas sent for
examination for reasons other than infection, that were normal histologically, 11.7% had CMV
detected by PCR; 90% of these were also positive by in situ hybdridization.45
By in situ
hybridization, CMV DNA localizes to the cytotrophoblast, syncytiotrophoblast, fetal capillaries
and villous stromal cells.45
Clinical features
CMV usually infects the fetus in utero. This may occur as a result of a primary maternal
infection during pregnancy, the pattern typically seen in women of higher socioeconomic status,
or after reactivation of latent viral infection, the pattern typical in women of lower
socioeconomic status.46
Usually infected women are asymptomatic. Primary maternal infection is
more likely to infect the fetus and these fetuses are more likely to be symptomatic.46
There is
evidence that decidual cells or decidual macrophages may serve as a reservoir for CMV and that
reactivation from these cells is enhanced as a result of the inflammatory response to concomitant
bacterial infections.47
In the United States, CMV is the most commonly identified infectious agent in cases of
villitis where an etiology is identified. About 1% of infants are born with congenital CMV
infection.46
About 5% to10% of these will have disseminated disease with hepatosplenomegaly,
jaundice, petechiae or death.46
Ninety percent of congenitally infected infants will have clinically
unrecognized disease and about 5% to15% of these will have long-term sequelae such as mental
retardation, learning disabilities and sensorineural hearing loss.48
These figures indicate that
congenital CMV infection represents an important public health problem. It is estimated that
nearly two billion dollars is spent annually in the U.S. on the care of symptomatic infants with
congenital CMV infection.49
Treatment of congenitally infected infants shortly after birth may decrease the severity of
neurologic damage and improve long-term outcome, therefore it is important for pathologists to
have a high level of suspicion for CMV and convey positive results immediately to the
pediatrician caring for these infants.50
There are no guidelines for treating CMV that occurs in
pregnancy, making the role of screening women for CMV infection unclear.49, 50
Villitis of Unknown Etiology (VUE)
The vast majority of cases of villitis represent villitis of unknown etiology (VUE) in
which an infectious etiology cannot be established. VUE will be seen in about 5% to 15% of
third trimester placentas.51
Nearly all cases occur after 32 weeks and 80% occur after 37 weeks
therefore villitis earlier than 32 weeks is more likely to have an infectious etiology.51
Gross and microscopic features
7
Placentas from most cases of VUE are normal on gross examination. Studies have shown
that the detection rate peaks at four blocks of tissue and that about 90% of cases are found with
sampling of two to three blocks.52
Villitis can be graded based on the amount of placental
parenchyma affected or on the number of villi involved per focus. Redline has proposed a
scheme in which the term low grade is applied to cases in which 10 or fewer villi are involved
per focus and high grade to cases with greater than 10 involved villi per focus. Focal describes
those cases with only one slide involved and multifocal those with more than one slide involved.
High grade cases can be separated into those that are patchy with less than 5% of all distal villi
involved and diffuse with more than 5% involvement.51
The vast majority of cases of VUE are
focal. In most cases the villitis is randomly distributed throughout the placenta but about 20%
have an exclusive or partial basal/parabasal distribution, often with associated decidual
inflammation.51
Most cases are necrotizing and the inflammatory cells are lymphocytes and
histiocytes. Plasma cells are not seen in VUE and their presence should suggest CMV or other
infectious etiologies. VUE may be associated with vasculitis of fetal stem vessels with
downstream avascular terminal villi.
Pathogenesis
There are two schools of thought about the pathogenesis of VUE. One proposes that VUE
is the result of an as yet unidentified infectious pathogen. Against this theory are the lack of
symptoms in patients, the lack of seasonal variation, and failure to identify a consistent pattern of
infection despite diligent searching with increasingly sophisticated techniques for several
decades.51
Another theory proposes that VUE is an immunologic phenomenon. This seems more
likely. The cells in foci of villitis have been demonstrated to be primarily maternal in origin and
to represent T cells with a CD4/CD8 ratio of in the range of 0.1 to 0.5, and macrophages that
exhibit up regulation of class II major histocompatability complex antigens.51
The findings
suggest a delayed hypersensitivity type or T-helper-1-type response as would be expected in an
allograft reaction, in this case host versus graft, between maternal and fetal tissues.51, 53
This
theory is also in keeping with clinical features such as an increased incidence of maternal
autoimmunity in women with placental VUE and the tendency for VUE to recur in some patients
in subsequent pregnancies.54
The target antigen of maternal attack is still not known.
Clinical significance
Most cases of VUE are focal and the fetus is unaffected. When diffuse, VUE has been
significantly associated with intrauterine growth restriction, oligohydramnios and chronic
monitoring abnormalities including abnormal non stress tests, abnormal pulsed flow Doppler
studies and abnormal biophysical profiles, diffuse perivillous fibrin deposition, and perinatal
mortality.51, 55
The more extensive and severe the villitis, the more likely that it will be associated
with adverse outcomes.51
Circulatory Disorders Circulatory disorders of the placenta are common and are frequently clinically important
for both the mother and the baby. It is important to keep in mind that the placenta has a dual
circulation. Maternal blood enters the intervillous space surrounding the villi through the uterine
spiral arteries. The blood percolating through this intervillous space provides nutrients to the
fetus. Deoxygenated fetal blood enters the placenta through the umbilical arteries which branch
over the chorionic plate and continue branching into the villous tree, ending in a capillary
network in the terminal villi. After nutrient exchange, oxygen-rich blood climbs up the villous
8
tree and is taken to the fetus via the umbilical vein. Disorders of the maternal circulation give
rise to one set of abnormalities and clinical problems while disorders of the fetal circulation give
rise to another.
Infarct
Gross Features
Placental infarcts are common lesions seen in about 10% to 25% of placentas from
normal term pregnancies.56, 57
Infarcts can vary in size and shape but are usually somewhat
triangular with the broad edge abutting the basal plate. They are commonly found in the
peripheral regions of the placenta. All infarcts are firmer than the surrounding placental tissue
and are typically very well circumscribed. Recent infarcts are dark red, firm and granular. With
age they become yellow and eventually white. Occasionally, central hemorrhage with cavitation
is seen.
Microscopic Features
In early infarction the villi are crowded together with narrowing or loss of the intervillous
space. The fetal vessels in the affected area are dilated and congested. The syncytiotrophoblast
nuclei show signs of degeneration such as nuclear pyknosis and karyorrhexis. With time, the
villous stroma and syncytiotrophoblast degenerate and eventually only "ghosts" of villi remain.58
The intervillous space no longer contains maternal red cells. Neutrophils and macrophages may
be seen at the periphery of a longstanding infarct but no true organization occurs, as occurs in
infarcts in other organs.
Differential Diagnosis
On gross examination, the differential diagnosis for infarcts includes perivillous fibrin
deposition and intervillous thrombohematoma. Perivillous fibrin is firm and yellow or white,
like an older infarct, but it is usually not as well circumscribed and often has areas of red villous
tissue interspersed with the white fibrin. Microscopically, there is expansion of the intervillous
space and proliferation of trophoblast within the fibrin. Intervillous thrombohematomas are well
circumscribed and firm like infarcts but they have a smooth, not granular cut surface, and are
usually laminated, since they contain only blood and fibrin and lack villous tissue.
Pathogenesis
Like infarcts elsewhere in the body, placental infarcts are caused by an interruption of the
blood supply to a portion of the placenta. It is maternal blood, percolating in the intervillous
space that supplies and nourishes the placenta. When this blood supply is cut off, the relatively
well circumscribed area of villous tissue supplied by a particular maternal vessel or group of
vessels undergoes infarction. This can occur because of vascular narrowing or occlusion of the
vessel as in atherosis (preeclampsia), with or without superimposed acute thrombosis, or because
the supplying maternal vessel is physically separated from the placenta, as in retroplacental
hematoma (placental abruption). Histologic sections of the decidua beneath an infarct may
demonstrate these pathologic changes. Often the decidua is extensively necrotic indicating that
the involved vessel is deep, near the myometrial-decidual junction. McDermott and Gillian have
presented evidence that infarcts are also accompanied by a concomitant reduction in fetal blood
flow to the villi in the infarcted area, manifesting as increased mineralization of the trophoblast
membrane.59
9
Clinical Significance
Extensive infarction, large infarcts (>3 cm), infarcts involving the central area of the
placenta, and infarcts in the first and second trimester are thought to be associated with
significant underlying maternal disease and interruption in the normal uteroplacental blood
flow.58, 60
Preeclampsia represents a major risk factor for infarction. There is a strong relationship
between the severity of preeclampsia and the extent of infarction.61
Increased rates of placental
infarction have also been reported in a variety of thrombophilic conditions including factor V
Leiden mutation heterozygosity, prothrombin gene variants, hyperhomocyteinemia, and
antiphospholipid antibodies.62-65
Extensive infarction may have serious consequences for the fetus including intrauterine
fetal demise, hypoxia, and intrauterine growth retardation both at term and in preterm infants.66-67
It is thought that the normal placenta can withstand the loss of as much as 15 to 20% of the
villous tissue without adversely affecting the fetus, but in conditions in which there is already
poor uteroplacental perfusion, such as preeclampsia, even lesser degrees of infarction may be
detrimental to the fetus. Lesions which cause a disturbance of uteroplacental circulation,
including extensive infarction, in the placentas of preterm infants has been significantly
associated with periventricular leukomalacia.68
High rates of infarction and low flow changes
were also noted in a series of stillborn infants with ischemic cerebral injury.69
However, this
association has not been found by all.70
Massive Perivillous Fibrin Deposition
Some fibrin is seen normally in most placentas and is particularly common beneath the
chorionic plate, around stem villi, and above the basal plate. This type of fibrin deposition is
thought to be due to local stasis and eddy currents in these areas and may actually reflect good
intraplacental blood flow, as this type of fibrin deposition is seen less commonly in placentas
from abnormal pregnancies such as those complicated by preterm delivery and diabetes.71
Gross Features
Large amounts of fibrinoid material can be appreciated grossly as firm white, yellow or
brown plaques. These may be slightly granular or smooth. Often they are located in the periphery
of the placenta where they fill in the angle where the fetal membranes meet the basal plate. Much
less commonly the fibrinoid material forms thick white or grey strands that replace much of the
placental parenchyma leaving only small pockets of interspersed red villous tissue.
Microscopic Features
Microscopically, the terminal villi are widely separated and enmeshed in an abundant
amount of eosinophilic fibrinoid material that obliterates the intervillous space. In early lesions,
the syncytiotrophoblast shows signs of degeneration and eventually disappears leaving behind a
thickened trophoblastic basement membrane. The trophoblast show a marked degree of
proliferation and extends out into the perivillous fibrin in clusters. The villous stroma becomes
progressively more fibrotic and eventually there is obliteration of fetal vessels.
In order to separate the normal amount of fibrin seen in the placenta from fibrin
deposition that is likely to be clinically significant, Katzman and Genest have proposed some
quantitative definitions.72
They define transmural massive perivillous fibrin deposition (MFD)
as perivillous fibrinoid material that extends from the maternal to the fetal surface encasing
greater than or equal to 50% of the villi on at least one slide.72
Borderline MFD is transmural or
nearly transmural and encases 25% to 50% of the villi on at least one slide.72
10
Differential Diagnosis
The differential diagnostic considerations include maternal floor infarct, placental infarct,
fibrin associated with chronic villitis and fibrinoid deposition after fetal death with retained
placenta. Maternal floor infarct overlaps significantly with massive perivillous fibrin deposition
and these entities are likely part of the same spectrum. Maternal floor infarct has similar
microscopic features, shares similar clinical features and often is associated with massive
perivillous fibrin deposition. By definition, maternal floor infarct involves the villi, and often the
decidua, near the maternal surface and should involve a large amount of the maternal floor.
Infarcts may be difficult to distinguish from perivillous fibrin deposition grossly as both may be
yellow or white and firm. Infarcts tend to be more sharply circumscribed and abut the maternal
surface of the placenta. Microscopically, infarcts show collapse rather than expansion of the
intervillous space, no trophoblast hyperplasia, and necrosis rather than fibrosis of the villous
stroma. Fibrin deposition associated with chronic villitis can be distinguished from massive
perivillous fibrin deposition because it usually has associated areas of active villitis. The clinical
history of intrauterine fetal demise will point to the correct diagnosis of villous fibrosis on this
basis. This is usually diffuse.
Clinical Features
Extensive perivillous fibrin deposition, while quite rare, involving less than 1% of
examined placentas, is an important lesion for pathologists to recognize because it is associated
with a high rate of adverse fetal outcome.72
What is likely to be clinically significant is the
location of the perivillous fibrin and the number of villi that are ischemic as a result of it. Redline
and Patterson observed that perivillous fibrin that entrapped more than 20% of the terminal villi
in the central basal portion of the placenta, which is thought to be the major nutrient-exchanging
region of the placenta, was significantly associated with intrauterine fetal growth retardation and
low placental weight.55
Although not as carefully localized or quantitated, a study by Fuke et al
also found a significant relationship between massive perivillous fibrin deposition and
intrauterine growth retardation.73
These workers observed that the combination of intrauterine
growth retardation and MFD could recur in subsequent pregnancies and could be prevented with
anticoagulant therapy.73
Katzman and Genest reported a 31% incidence of IUGR in cases with
MFD.72
About 14% of their cases had recurrent MFD or maternal floor infarct in subsequent 2nd
or 3rd
trimester placentas and 50% had increased perivillous fibrin or maternal floor infarct in 1st
trimester placentas.72
Kumazaki et al found a significant relationship between lesions which
cause a disturbance of uteroplacental circulation, including MFD, in the placentas of preterm
infants and periventricular leukomalacia.68
Retroplacental Hematoma/Placental Abruption
Gross Features
A retroplacental hematoma is a blood clot that lies between the basal plate of the placenta
and the uterine wall and indents the overlying placental parenchyma. It may be large, covering
most of the maternal surface, or small, best visualized on serial sections. A recent retroplacental
hematoma will be soft and red and will easily separate from the placenta. An indentation, a
disrupted maternal surface, a large amount of clot in the specimen container, the delivering
physician's impression of the placenta when delivered or at the time of Cesarean section may all
point to the diagnosis in the absence of adherent clot on the placenta. Older hematomas are firm,
brown and adherent. Sometimes the placental parenchyma overlying retroplacental hematomas is
infarcted, particularly if the hematoma is not very recent. Occasionally a hematoma may rupture
11
and dissect into adjacent villous tissue. In a very recent retroplacental bleed there may be no clot
adherent to the placenta and no deformation of the maternal surface.
Microscopic Features
Early hematomas are composed of red cells while older ones contain varying amounts of
fibrin, degenerated red cells, hemosiderin-laden macrophages and neutrophils. The overlying
decidua may be necrotic. Villous stromal hemorrhage and villous edema may be seen adjacent to
retroplacental hematoma, particularly when the hematoma occurs in the second trimester.74
Retroplacental hematomas, particularly large hematomas and those that are not recent, may be
associated with infarction.
Clinical Features
Retroplacental hematomas are common, occurring in as many as 4.5% of placentas.75
The
most consistently identified risk factors for retroplacental bleeding include preeclampsia with a
three fold increased risk, abdominal trauma, cigarette smoking, both maternal and of the male
partner, a previous history of abruption, extremes of maternal age, multiparity, poor nutrition,
low socioeconomic status, acute chorioamnionitis, severe fetal growth retardation, maternal
thrombophilic conditions, and cocaine abuse.75-79
Retroplacental hematoma is related to, but not synonymous with, the clinical syndrome of
placental abruption (abruptio placentae). The features of this clinical syndrome include vaginal
bleeding, increased uterine tone, uterine tenderness, diminished fetal heart tones and if severe,
maternal hypovolemia, consumptive coagulopathy, and fetal death.80
The incidence of abruption
is about 11.5/1000 deliveries.76
It is associated with a 20% to 40% fetal mortality rate and
accounts for 10% of all stillbirths and 6% of all maternal deaths in developed countries.76
The
rate of placental abruption in the United States has increased in the last few decades.76
Retroplacental hematoma and placental abruption share many of the same risk factors and
a clear distinction between them has not always been made in the literature. There is poor
concordance between the clinical and pathologic criteria for abruption/retroplacental
hematoma.81
In only about a third of the cases with a clinical diagnosis of abruption can a
retroplacental hematoma be demonstrated on placental examination, probably because of the
rapidity of development and subsequent delivery.82
Conversely, in only about a third of cases in
which the pathologist identifies a retroplacental hematoma will the clinical syndrome of
placental abruption have been diagnosed.82
These probably represent smaller, clinically
insignificant hematomas.
The clinical significance of retroplacental hematoma is largely dependant on the size and
the amount of placenta that is infarcted, keeping in mind that in a background of chronic
uteroplacental ischemia, such as with preeclampsia, the functional reserve of the placenta will be
exceeded with lesser degrees of infarction. Gross lesions with disturbance of uteroplacental
circulation, including massive retroplacental hematoma has been associated with periventricular
leukomalacia in preterm infants.68
Extensive retroplacental hematoma with infarction may also
cause fetal death.83
Pathogenesis
The pathogenesis of retroplacental hematoma is not well understood. It is thought that in
cases of preeclampsia the associated atherosis may weaken the vessels increasing the likelihood
of rupture. Cigarette smoking and cocaine abuse may also damage vessels walls.
Hyperhomocysteinemia and hereditary deficiencies in various factors involved in normal
coagulation may also lead to repeated thrombosis and possibly vascular damage.
12
Fetal Thrombotic Vasculopathy Occlusion of vessels in the fetal circulatory system can involve vessels at any level -
large umbilical cord vessels, their branches on the chorionic plate, or smaller capillary fetal
vessels within the chorionic villi. During gestation there is one continuous circulation between
the fetus and the placenta. The term fetal vascular obstruction used in this discussion refers to
thrombi, or related downstream lesions, in the fetal portion of the placental circulation. It has
become increasingly clear that thrombotic lesions in the placental part of this fetal circulation
may be associated with, and could serve as a marker for, thrombotic or embolic lesions in the
circulation of the fetus itself, sometimes with devastating consequences for the fetus. For this
reason, it is important for pathologists to become familiar with the gross and microscopic
appearance of fetal vascular obstructive lesions in the placenta.
Gross and Microscopic Features
Areas of avascular terminal villi downstream from vascular obstruction in the placenta or
cord form well circumscribed, pale areas with the same spongy consistency as the surrounding
placental tissue. The affected villi are sharply demarcated, both grossly and microscopically,
from adjacent normal villi. Microscopically, the villi are avascular and the villous stroma
exhibits an increased amount of bland eosinophilic stromal hyaline fibrosis. The villi are
normally spaced within the intervillous space.
Redline et al. recently proposed diagnostic terminology with precise, reproducible
definitions for lesions of fetal vascular obstruction.20
The term uniformly avascular villi is used
when three or more foci of two terminal villi show avascularity. Another form of fetal vascular
obstruction that manifests in distal villi has been termed villous stromal-vascular karyorrhexis.
This can be diagnosed when three or more foci of two or more terminal villi show karyorrhexis
of fetal cells either endothelium, stromal cells or blood cell elements.20
Often the villi are
hypovascular with degenerating capillaries and fragmented red cells. This lesion has been termed
hemorrhagic endovasculitis in the past. It is now thought to represent part of the spectrum of
changes in fetal vascular obstruction as both patterns may coexist, both share the same
predisposing risk factors and both carry similar implications for the fetus.20
All of these villous
changes are considered severe when there are more than two foci that average 15 or more villi
per focus per slide.20
It is recommended that the term fetal thrombotic vasculopathy be reserved
for those cases in which the villous vascular obstruction is this extensive. Massive thrombosis
may involve 25 to 50% of the placental parenchyma.84
A thrombosed large vessel upstream from avascular terminal villi or villous stromal-
vascular karyorrhexis can only be demonstrated in about a third of cases when extensive
avascular villi are present.85
The distal villous changes may be more sensitive and reproducible
evidence of fetal thrombotic vasculopathy than thrombotic lesions in large vessels.86
Differential Diagnosis
The differential diagnosis on gross examination is primarily with an infarct. Both an
infarct and an area of avascular terminal villi will be well circumscribed and all but very recent
infarcts will be pale. In contrast to areas of avascular villi which have the same spongy
consistency as the surrounding placental tissue, infarcts are always more firm than surrounding
tissue. Microscopically, infarcts will show crowded villi with collapse of the intervillous space,
whereas the villi in fetal vascular obstruction will be normally spaced. The villi in infarcts
13
exhibit ischemic necrosis whereas those in fetal vascular obstruction show dense, eosinophilic
stromal fibrosis.
Another differential diagnostic consideration, especially on microscopic examination, is
with the villous changes associated with intrauterine fetal demise. The microscopic changes may
be very similar to fetal vascular obstruction, but with intrauterine fetal demise, the process is
generalized involving all villi and all vessels of a similar size to the same degree, in contrast to
the sharply demarcated areas of avascularity in fetal vascular obstruction.
A third process in the differential diagnosis is villitis of unknown etiology with stem
villitis and avascular villi.20
In this condition, the placenta will show areas of active and healed
villitis with villitis involving the stem villi, including the vessels which show obliteration and
downstream avascular villi. This diagnosis should only be made in the setting of active villitis.
Pathogenesis
Thrombotic vascular obstruction in the fetal circulation may have several mechanisms,
including a hypercoagulable state, vascular damage and stasis.85
Fetal coagulation factor
abnormalities or hereditary thrombophilias in the fetus alone probably explain very few of these
cases but may provide a substrate that when combined with other factors can tip the balance
towards thrombosis.87, 88
There is an association between fetal thrombotic vasculopathy and a
variety of cord abnormalities including velamentous cord insertion, excessive cord twisting,
nuchal cord, other encirclements, and very long cords.85
These cord abnormalities promote
vascular stasis and the development of clot which may be propagated with downstream effects or
embolize downstream or into the circulation of the fetus itself. There is also an association
between fetal vascular obstruction and chorioamnionitis. The mediators of the inflammatory
process trigger the coagulation cascade at several points. The incidence of thrombosis in the
placental part of the fetal circulation is also increased in the placentas of diabetic mothers for
reasons that are not well understood.89
Clinical Features
Very extensive avascular villi, involving 40 to 60% of the placental tissue, may cause
sudden intrauterine or intrapartum fetal death due to massive placental dysfunction.90
Fetal
thrombotic vasculopathy as defined above, is associated with cerebral palsy, perinatal liver
disease, fetal and neonatal thromboembolic disease and discordant growth in twins.85
Fetal vascular obstructive lesions in fetal circulation of the placenta may be associated
with thrombotic lesions in the fetus itself or with fetal conditions such as cerebral palsy that may
have thrombosis as part of its pathogenesis. Redline and Pappin, using avascular villi as a
marker of this process, found that cases with extensive areas of avascular villi were significantly
associated with fetal growth retardation, oligohydramnios in the absence of membrane rupture
and acute and chronic monitoring abnormalities.86
In a subset of this group that was over 34
weeks, did not have malformations and did not have other major placental pathology, the
presence of very large areas of avascular villi, diffuse platelet aggregates or intravascular fibrin
strands was highly associated with major thrombotic events in the fetus.86
In a study of term,
singleton infants with neonatal encephalopathy, McDonald et al found that fetal thrombotic
vasculopathy, as well as funisitis and accelerated villous maturation were all independently and
significantly associated with neonatal encephalopathy.91
Kraus has described a high rate of
downstream avascular villi and thrombi in fetal placental vessels in a selected group of infants
with cerebral palsy referred for the purpose of litigation.92
Redline et al, studying a similar
population, also found extensive avascular villi in about 18% of term cases with long-term
neurologic impairment.93
Potentially obstructing umbilical cord abnormalities were much more
14
likely in infants with fetal thrombotic vasculopathy. In a study of 84 consecutive perinatal
autopsies, Kraus found fetal vascular obstructive lesions in the placentas of 16 cases.94
The areas
of fetal vascular obstructive lesions were extensive in the placentas of all cases and occupied 25
to 40% of the placenta in four cases. In these four cases, the extensive fetal vascular obstructive
lesions were the only explanation for the fetal death. Six of these cases had thrombi in fetal
organs including the brain, kidney and lungs. Eight of the mothers had an extensive work up for
coagulopathy and five had one or more coagulation abnormalities.94
These findings indicate that fetal vascular obstructive lesions in the placenta, particularly
if extensive, may be a reliable indicator of the potential for thrombi in the circulation of the fetus
or newborn and may explain adverse perinatal outcomes and some perinatal deaths. It should be
clear that the process of thrombosis occurs well before labor and delivery. Prospective studies
will be needed to determine the predictive value of fetal vascular obstructive lesions for various
adverse fetal outcomes such as neurologic impairment. Further studies are also needed to
determine the clinically significant amount of avascular villi, the appropriate work up for this
finding, and what role, if any, there is for treatment in subsequent pregnancies.
References:
1. Driscoll SG. Pathology and the developing fetus. Pediatr Clin North Am. 1965;12:493.
2. Wu X, Faye-Petersen OM, Steinkampf JL, Richardson TJ, Reilly SD. The impact of
placental examination in the autopsy of the structurally normal stillborn. Mod Pathol 2009;
22(supplement 1): 10A poster 33.
3. Heazell AEP, Martindale EA. Can post-mortem examination of the placenta help determine
the cause of stillbirth? J Obstet Gynaecol 2009; 29(3): 225-228.
4. Lambird PA. Resource allocation and cost of quality. Arch Pathol Lab Med 1990:114:1168-
1172.
5. Kraus FT. Perinatal pathology, the placenta, and litigation. Human Pathol 2003; 34(6):517-
520.
6. Mueller-Heubach E,.Rubinstein DN, Schwarz SS. Histologic chorioamnionitis and preterm
delivery in different patient populations. Obstet Gynecol 1990;75:622-626.
7. Naeye RL, Blanc WL. Relation of poverty and race to antenatal infection. N Engl J Med
1965; 283:555-560.
8. Kraus FT, Redline RW, Gersell DJ, Nelson DM, Dicke JM. Placental Pathology. Atlas of
Nontumor Pathology, American Registry of Pathology. Washington, DC. 2004, p. 78.
9. Cooperman NR, Kasim M, Rajashekaraiah KR. Clinical significance of amniotic fluid,
amniotic membranes, and endometrial biopsy cultures at the time of cesarean section. Am J
Obstet Gynecol 1980; 137:536-542.
10. Goldenberg RL, Hauth JC, Andrew WW. Intrauterine infection and preterm delivery. N
Engl J Med 2000; 342:1500-1507.
11. Gersell DJ, Kraus FT. Diseases of the Placenta. In: Ed. Robert J. Kurman. Blaustein’s
Pathology of the Female Genital Tract, 5th
Edition. Springer-Verlag, New York, 2002, p.
1199.
12. Redline RW, Faye-Petersen O, Heller D, Qureshi R, Savell V, Vogler C, and the Society for
Pediatric Pathology, Perinatal Section, Amniotic Fluid Infection Nosology Committee.
Pediatr Dev Pathol. 2003; 6:435-448.
13. Gomez R, Ghezzi F. Romero R, Munoz H, Tolosa JE, Rojas I. Premature labor and intra-
amniotic infection. Clinical aspects and role of the cytokines in diagnosis and
pathophysiology. Clin Perinatol 1995; 22:281-342.
15
14. Stallmach T, Hebisch G, Joller-Jemelka HI, Orban P, Schwaller J, Engelmann M. Cytokine
production and visualized effects in the fetomaternal unit. Quantitative and topographic data
on cytokines during intrauterine disease. Lab Invest 1995; 73:384-392.
15. Parry S, Strauss JF. Premature rupture of the fetal membranes. N Engl J Med 1998;
338:663-670.
16. Gotsch F, Romero R, Kusanovic JP, Mazaki-Tovi S, Pineles BL, Erez O, Espinoza J, Hassan
SS. The fetal inflammatory response syndrome. Clinical Obstet Gynecol 2007; 50(3):652-
683.
17. Gomez R, Romerio R, Ghezzi F, Yoon BH, Mazor M, Berry SM. The fetal inflammatory
response syndrome. Am J Obstet Gynecol 1998; 179:194-202.
18. Kim CJ, Yoon, BH, Romero R. Umbilical arteritis and phlebitis mark different stages of the
fetal inflammatory response. Am J Obstet Gynecol 2001;185:496-500.
19. Rogers BB, Alexander JM, Head J, McIntire D, Leveno KJ. Umbilical vein interleukin-6
levels correlate with the severity of placental inflammation and gestational age. Hum Pathol
2002; 33:335-340.
20. Redline RW, Ariel I, Baergen RN, Desa DJ, Kraus FT, Roberts DJ, Sander CM. Fetal
vascular obstructive lesions: nosology and reproducibility of placental reaction patterns.
Pediatr Dev Pathol 2004; 7(5):443-52.
21. Eastman NJ, Deleon M. The etiology of cerebral palsy. Am J Obstet Gynecol 1955;69:950-
961.
22. Nelson KB, Ellenberg JH. Epidemiology of cerebral palsy. Adv. Neurol 1978;19: 421-435.
23. Grether JK, Nelson KB. Maternal infection and cerebral palsy in infants of normal birth
weight JAMA 1997; 278:207-211.
24. Wu Y, Colford J. Chorioamnionitis as a risk factor for cerebral palsy: a meta-analysis.
JAMA 2000;284(11):1417-24.
25. Yoon BH et al. Intrauterine infection and the development of cerebral palsy. BJOG
2003;110:124-127.
26. Yoon BH, Kim CJ, Romero R et al. Experimentally induced intrauterine infection causes
fetal brain white matter lesions in rabbits. Am J. Obstet Gynecol 1997; 177:797-802.
27. Yoon BH, Jun JK, Romero R et al. Amniotic fluid inflammatory cytokines (interleukin-6,
interleukin-1beta, and tumor necrosis factor-alpha), neonatal brain white matter lesions, and
cerebral palsy. Am J Obstet Gynecol 1997; 177:19-26.
28. Yoon BH, Romero R, Park JS. et al. Fetal exposure to an intra-amniotic inflammation and
the development of cerebral palsy at the age of three years. Am J Obstet Gynecol 2000;
182;675-681.
29. Grafe MR. The correlation of prenatal brain damage with placental pathology. J
Neuropathol Exp Neurol 1994;53:407-415.
30. Redline RW. Severe fetal placental vascular lesions in term infants with neurologic
impairment. Am J Obstet Gynecol 2005;192:452-457.
31. Mittendorf R, Montag AG, MacMillan W, Janeczek S, Pryde PG, Besinger RE. Components
of the systemic fetal inflammatory response syndrome as predictors of impaired neurologic
outcomes in children. Am J Obstet Gynecol 2003; 188:1438.
32. Leviton A. Preterm birth and cerebral palsy: is tumor necrosis factor the missing link? Dev
Med Child Neurol 1993;35:553-558.
33. Yoon BH, Park C-W, Chaiworapongsa T. Intrauterine infection and the development of
cerebral palsy. BJOG 2003;110 supplement 20: 124-127.
16
34. Gibson CS, Maclennan AH, Dekker GA, Goldwater PN, Sullivan TR, Munroe DJ, Tsang S,
Stewart C, Nelson KB. Candidate genes and cerebral palsy: a population-based study.
Pediatrics 2008;122(5):1079-85.
35. Gibson CS, MacLennan AH, Goldwater PN, Haan EA, Priest K, Dekker GA, South
Australian Cerebral Palsy Research Group. The association between inherited cytokine
polymorphisms and cerebral palsy. Am J Obstet Gynecol 2006;194(3):674.e1-11.
36. O’Callaghan ME, MacLennan AH, Haan EA, Dekker G, South Australian Cerebral Palsy
Research Group. The genomic basis of cerebral palsy; a HuGE systematic literature review.
Hum Gene 2009; 126(1):149-72.
37. Mittendorf R, Covert R, Montag AG, el Masri W, Muraskas J, Lee K-S, Gryde PG. Special
relationships between fetal inflammatory response syndrome and bronchopulmonary
dysplasia in neonates. J Perinat Med 2005;33:428-434.
38. Yoon BH, Romero R, Jun JK, Park JD, Ghezzi F, et al. Amniotic fluid cytokines
(interleukin-6, tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8) and the risk
for the development of bronchopulmonary dysplasia. Am J. Obstet Gynecol 1997; 177:825.
39. Ghezzi F, Gomez R, Romero R et al. Elevated interleukin-8 concentrations in amniotic fluid
of mothers whose neonates subsequently develop bronchopulmonary dysplasia. Eur J Obstet
Gynecol Reprod Biol. 1998; 78:5-10.
40. Redline R, Patterson R. Villitis of unknown etiology is associated with major infiltration of
fetal tissues by maternal cells. Am J Pathol 1993; 143:332-336.
41. Mostoufi-Zadeh M, Driscoll SG, Biano SA, Kundsin RB. Placental evidence of
cytomegalovirus infection of the fetus and neonate. Arch Pathol Lab Med 1984; 108:403-6.
42. Sachdev R, Nuovo GJ, Kaplan C, Greco MA. In situ hybridization analysis for
cytomegalovirus in chronic villitis. Ped Pathol 1990; 10:909-917.
43. Muhlmann K, Miller RK, Metlay L, Menegus MA. Cytomegalovirus infection of the human
placenta: an immunohistochemical study. Hum Pathol 1992; 23:124-137.
44. Ozono K, Mushiake S, Takeshima T, Nakayama M. Diagnosis of congenital cytomegalovirus
infection by examination of the placenta: application of polymerase chain reaction and in situ
hybridization. Ped Pathol Lab Med 1997;17:249-258.
45. Trincado DE, Munro SC, Camaris C, Rawlinson WD. Highly sensitive detection and
localization of maternally acquired human cytomegalovirus in placental tissue by in situ
polymerase chain reaction. JID 2005;192;650-7.
46. Stagno S, Pass RF, Duorsky ME, Henderson RE, Moore EG, Walton PD, Alford CA.
Congenital cytomegalovirus infection: the relative importance of primary and recurrent
maternal infection. NEJM 1982; 306:945-949.
47. Pereira L, Maidji E, McDonagh S, Genbacev O, Fisher S. Human cytomegalovirus
transmission from the uterus to the placenta correlates with the presence of pathogenic
bacteria and maternal immunity. J Virol 2003; 77:13301-13314.
48. Stagno S, Whitley RJ. Herpesvirus infections of pregnancy: part 1- cytomegalovirus and
Epstein-Barr virus infections. NEJM 1985; 313:1270-1274.
49. Halvachs-Baumann G, Gensen B, Danda M, Engele H, Rosegger H, Folsch B, Maurer U,
Lackner H, Truschnig-Wilders M. Screening and diagnosis of congenital cytomegalovirus
infection: a 5 year study. Scand J Infect Dis 2000; 32:137-142.
50. Modlin JF, Grant E, Makar RS, Roberts DJ, Krishnamoorthy KS. 25-2003; a newborn boy
with petechiae and thrombocytopenia. NEJM 2003; 349:691-700.
51. Redline RW. Villitis of unknown etiology: noninfectious chronic villitis in the placenta.
Hum Pathol 2007; 38:1439-1446.
17
52. Knox WR, Fox H. Villitis of unknown aetiology: its incidence and significance in placentae
from a British population. Placenta 1984; 5:395-402.
53. Kim MJ, Romero R, Kim CJ et al. Villitis of unknown etiology is associated with a distinct
pattern of chemokine up-regulation in the feto-maternal and placental compartments:
implications for conjoint maternal allograft rejection and maternal anti-fetal graft-versus-host
disease. J Immunol 2009; 182:3919-3927.
54. Redline RW, Abramowsky CR. Clinical and pathologic aspects of recurrent placental
villitis. Hum Pathol 1985; 16:727-31.
55. Redline RW, Patterson P. Patterns of placental injury: correlations with gestational age,
placental weight, and clinical diagnosis. Arch Pathol Lab Med 1994; 18:698-701.
56. Wallenburg HCS, Stolte LAM, Janssens J. The pathogenesis of placental infarction I. A
morphologic study in the human placenta. Am J Obstet Gynecol 1973; 116:835-40.
57. Becroft DMO, Thompson JMD, Mitchell EA. The epidemiology of placental infarction at
term. Placenta 2002; 23:343-351.
58. Fox H. White infarcts of the placenta. J Obstet Gynecol Br Com 1963; 70:980-991.
59. McDermott M, Gillan JE. Chronic reduction in the fetal blood flow is associated with
placental infarction. Placenta 1995; 16:165-170.
60. Kraus FT, Redline RW, Gersell DJ, Nelson DM, Dicke JM. Placental Pathology. Atlas of
Nontumor Pathology, American Registry of Pathology. Washington, DC. 2004, p.124-125.
61. Moldenhauer JS, Stanek J, Warshak C, Khoury J, Sibai B. The frequency and severity of
placental findings in women with preeclampsia are gestational age dependent. Am J Obstet
Gynecol 2003;189:1173-7.
62. Dizon-Towson DS, Meline L, Nelson LM, Varner M, Ward K. Fetal carriers of the factor V
Leiden mutation are prone to miscarriage and placental infarction. Am J Obstet Gynecol
1997;177(2): 402-405.
63. Goddijn-Wessel TA, Wouters MG, van de Molen EF, Spuijbrock MD, Steegers-Theunissen
RP, Blom HJ, Boers GH, Eskes TK. Hyperhomocysteinemia: a risk factor for placental
abruption or infarction. Eur J Obstet, Gynecol, Repro Biol. 1996; 66(1):23-29.
64. Out HJ, Kooijman CJ, Bruinse HW, Derksen RH. Histopathological findings in placentae
from patients with intra-uterine fetal death and anti-phospholipid antibodies. Eur J Obstet,
Gyn, Repro Bio. 1991;41(3):179-186.
65. Many A. Schreiber L, Rosner S. Lessing JB, Eldor A, Kupferminic MJ. Pathologic features
of the placenta in women with severe pregnancy complications and thrombophilia. Obstet
Gynecol 2001; 98:1041-1044.
66. Salafia CM, Vintzileos AM, Silberman L, Bantham KE, Vogel CA. Placental pathology of
idiopathic intrauterine growth retardation at term. Am J. Perinatol 1992;9:179-184.
67. Salafia CM, Minior VK, Pezzullo JC, Popek EJ, Rosenkrantz TS, Vintzileos AM.
Intrauterine growth restriction in infants of less than thirty-two weeks gestation: associated
placental pathologic features. Am J Obstet Gynecol 1995; 173:1049-1057.
68. Kumazaki K, Nakyama M, Sumida Y, Ozono K, Mushiake S, Suehara N, Wada Y, Fujimura
M. Placental features in preterm infants with periventricular leukomalacia. Pedatrics 2002;
109(4): 650-655.
69. Burke C, Tannenberg AE. Prenatal brain damage and placental infarction – an autopsy
study. Devel Med Child Neurol 1995;37:555-562.
70. Gray PH, O’Callaghan MJ, Harvey JM, Burke CJ, Payton DJ. Placental pathology and
neurodevelopment of the infant with intrauterine growth restriction. Develop Med Child
Neurol 1999; 41:16-20.
18
71. Fox H. Perivillous fibrin deposition in the human placenta. Am J. Obstet Gynecol 1976;
8:245-51.
72. Katzman PJ, Genest DR. Maternal floor infarction and massive perivillous fibrin deposition:
histologic definitions, associations with intrauterine fetal growth restriction, and risk of
recurrence. Pediatr Dev Pathol 2002;5:159-164.
73. Fuke Y, Aono T, Imai S, Suehara N, Fijita T, Nakayama M. Clinical significance and
treatment of massive intervillous fibrin deposition associated with recurrent fetal growth
retardation. Gynecol Obstet Invest 1994; 38:5-9.
74. Mooney EE, Shunnar AA, O’Regan M, Gillan JE. Chorionic villous haemorrhage is
associated with retroplacental haemorrhage. Br J Obstet Gynaecol 1994; 101:965-969.
75. Kramer MS, Usher RH, Pollack R, Boyd M, Usher S. Etiologic determinants of abruption
placentae. Obstet Gynecol 1997;89:221-226.
76. Saftlas AF, Olson DR, Atrash HK, Rockat R, Rowley D. National trends in the incidence of
abruption placentae, 1979-1987. Obstet Gynecol 1991; 78:1081.
77. Hibbard BM, Jeffcoate TNA. Abruptio Placentae. Obstet Gynecol 1966;27:155-167.
78. Nath CA. Ananth CV, Smulian JC, Shen-Schwarz S, Kaminsky L. Histologic evidence of
inflammation and risk of placental abruption. Am J Obstet Gynecol 2007; 197:319.e1-
319.e6.
79. Oyelese Y, Ananth CV. Placental abruption. Obstet Gynecol 2006;108:1005-1016.
80. Tikkanen M, Nuutila M,Hilesmaa V, Paavonen J. Ylikorhalo O. Clinical presentation and
risk factors of placental abruption. Acta Obstet Gynecol 2006;85:700-705.
81. Elsasser DA, Ananth CV, Prasad V, Vintzileos AM. Diagnosis of placental abruption:
relationship between clinical and histopathological findings. Eur J Obstet Gynecol Reprod
Biol. 2009. Nov 6, Epub
82. Gersell DG, Kraus FT in Blaustein’s Pathology of the Female Genital Tract, 4th
ed, ed.
Robert J. Kurman, New York, Springer-Verlag. 2002; pp.1138-1140.
83. Naeye RL, Harkness WL, Utts J. Abruptio placentae and perinatal death: a prospective
study. Am J Obstet Gynecol 1977; 128:740-746.
84. Kraus FT, Redline RW, Gersell DJ, Nelson DM, Dicke JM. Placental Pathology. Atlas of
Nontumor Pathology, American Registry of Pathology. Washington, DC. 2004, p. 146.
85. Redline RW. Clinical and pathological umbilical cord abnormalities in fetal thrombotic
vasculopathy. Hum Pathol 2004;35:1494-1498.
86. Redline RW, Pappin A. Fetal thrombotic vasculopathy: the clinical significance of extensive
avascular villi. Hum Pathol 1995;26:80-85.
87. Khong TY, Hague WM. Biparental contribution to fetal thrombophilia in discordant twin
intrauterine growth restriction. Am J Obstet Gynecol 2001; 185:244-245.
88. Ariel I, Anteby E, Hamani Y, Redline RW. Placental pathology in fetal thrombophilia. Hum
Pathol 2004; 35:729-733.
89. Fox H. Thrombosis of the foetal arteries in the human placenta. J Obstet Gynaecol Br
Commonw 1966; 73:961-968.
90. Kraus FT, Redline RW, Gersell DJ, Nelson DM, Dicke JM. Placental Pathology. Atlas of
Nontumor Pathology, American Registry of Pathology. Washington, DC. 2004, p. 141.
91. McDonald DGM, Kelenhan P, McMenamin JB, Gorman WA, Madden D, Tobbia IN,
Mooney EE. Placental fetal thrombotic vasculopathy is associated with neonatal
encephalopathy. Hum Pathol 2004; 35:875-880.
92. Kraus FT. Cerebral palsy and thrombi in placental vessels of the fetus: insights from
litigation. Hum Pathol 1997;28:246-8.
19
93. Redline RW, O’Riordan MA. Placental lesions associated with cerebral palsy and neurologic
impairment following term birth. Arch Pathol Lab Med. 2000; 124:1785-1791.
94. Kraus FT, Acheen VI. Fetal thrombotic vasculopathy in the placenta: cerebral thrombi and
infarct, coagulopathies, and cerebral palsy. Hum Pathol 1999;30:759-69.
Top Related